Articles


Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine

September 1, 2010

You can view this news at http://www.businesswire.com/news/home/20100901005558/en.

 

 

 

Most Popular

Need Information?

Please wait... busy